This document is a quick and concise evidence-based summary to provide additional information, instruction, or guidance to complement a treatment protocol or clinical resource document.
Australian consensus guidelines for the management of neutropenic fever in adult cancer patients: Levels of evidence and grades of recommendations.
The levels of evidence and grades of recommendations used in these guidelines (table below) are taken from the ‘National Health and Medical Research Council (NHMRC) additional levels of evidence and grades for recommendations for developers of guidelines’.r
| Grade of recommendation |
Description |
| A |
Body of evidence can be trusted to guide practice |
| B |
Body of evidence can be trusted to guide practice in most situations |
| C |
Body of evidence provides some support for recommendation(s), but care should be taken in its application |
| D |
Body of evidence is weak and recommendation must be applied with caution |
While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information source. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au
Send feedback for this page
- Last reviewed:
-
- Review due:
-
The currency of this information is guaranteed only up until the date of printing, for any updates please check:
https://www.eviq.org.au/p/3067
19 Apr 2024